Soluble Adhesion Molecules, Cytokines and Cellular Markers in Serum in Patients with Acute Infections

References

• Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995; 55: 125–31.
   Google Scholar
• Fjaertoft G, Hakansson L, Ewald U, Foucard T, Venge P. Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res 1999; 45: 871–6.
   Google Scholar
• Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767–804.
   PubMed Web of Science ®Google Scholar
• Venge P. Eosinophil and neutrophil granulocytes. Allergy 1993; 48 (17 Suppl): 39–47.
   PubMedGoogle Scholar
• Venge P, Bergstrand H, Håkansson L. Neutrophils and eosinophils. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia, PA: WB Saunders, 1996: 146–60.
   Google Scholar
• Öberg G, Venge P. Bone-marrow regeneration after therapyinduced hypoplasia monitored by serum measurements of lactoferrin, lysozyme and myeloperoxidase. Scand J Haematol 1986; 37: 130–6.
   PubMedGoogle Scholar
• Öberg G, Dahl R, Ellegaard J, Sundström C, Vaeth M, Venge P. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, highlactoferrin AML. Eur J Haematol 1987; 38: 148–55.
   PubMed Web of Science ®Google Scholar
• Öberg G, Simonsson B, Smedmyr B, Tötterman Th, Venge P. Myeloid regeneration after bone-marrow transplantation monitored by serum measurements of myeloperoxidase, lysozyme and lactoferrin. Eur J Haematol 1987; 38: 356–62.
   PubMed Web of Science ®Google Scholar
• Konstan MW, Chen PW, Sherman JM, Thomassen MJ, Wood RE, Boat TF. Human lung lysozyme: sources and properties. Am Rev Respir Dis 1981; 123: 120–4.
   PubMed Web of Science ®Google Scholar
• Venge P. The monitoring of inflammation by specific cellular markers. Scand J Clin Lab Invest 1994; 219 (Suppl): 47–54.
   Google Scholar
• Selvaraj P, Kannapiran M, Reetha AM, Uma H, Xavier T, Narayanan PR. HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 265–9.
   PubMedGoogle Scholar
• Near KA, Lefford MJ. Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis. J Clin Microbiol 1992; 30: 1105–10.
   PubMedGoogle Scholar
• Moriwaki Y, Kohjiro N, Itoh M, Nakatsuji Y, Okada M, Ishihara H, et al. Discrimination of tuberculous from carcinomatous pleural effusion by biochemical markers: adenosine deaminase, lysozyme, fibronectin and carcinoembryonic antigen. Jpn J Med 1989; 28: 478–84.
   PubMedGoogle Scholar
• Hersh EM, Mansell PW, Reuben JM, Rios A, Newell GR. Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style. Cancer Res 1984; 44: 5894–901.
   Google Scholar
• Grieco MH, Reddy MM, Kothari HB, Lange M, Buimovici-Klein E, William D. Elevated beta 2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol 1984; 32: 174–84.
   Google Scholar
• Helman CA, Novis BH, Bank S, Wormold L, Jacobs P. Serum lysozyme in Crohn’s disease and ulcerative colitis. S Afr Med J 1977; 52: 1042–4.
   Google Scholar
• Pruzanski W, Ogryzlo MA. Lysozyme in rheumatic diseases. Semin Arthritis Rheum 1972; 1: 361–81.
   PubMedGoogle Scholar
• Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989; 142: 808–12.
   PubMed Web of Science ®Google Scholar
• Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111: 201–9.
   PubMed Web of Science ®Google Scholar
• Venge P, Hällgren R, Stålenheim G, Olsson I. Effects of serum and cations on the selective release of granular proteins from human neutrophils during phagocytosis. Scand J Haematol 1979; 22: 317–26.
   PubMedGoogle Scholar
• Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992; 77: 543–9.
   PubMed Web of Science ®Google Scholar
• Arkin S, Naprstek B, Guarini L, Ferrone S, Lipton JM. Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors. Blood 1991; 77: 948–53.
   Google Scholar
• Shingu M, Hashimoto M, Nobunaga M, Isayama T, Yasutake C, Naono T. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients. Inflammation 1994; 18: 23–34.
   PubMed Web of Science ®Google Scholar
• Shen J, To SS, Schrieber L, King NJ. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J Virol 1997; 71: 9323–32.
   PubMedGoogle Scholar
• Vitale G, Mansueto S, Gambino G, Mocciaro C, La Russa C, Mansueto P, et al. Differential up-regulation of circulating soluble selectins and endothelial adhesion molecules in Sicilian patients with Boutonneuse fever. Clin Exp Immunol 1999; 117: 304–8.
   PubMedGoogle Scholar
• Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998; 44: 469–77.
   PubMed Web of Science ®Google Scholar
• Esterre P, Raobelison A, Ramarokoto CE, Ravaoalimalala VE, Boisier P, Roux J. Serum concentrations of sICAM-1, sE-, sP- and sL-selectins in patients with Schistosoma mansoni infection and association with disease severity. Parasite Immunol 1998; 20: 369–76.
   PubMedGoogle Scholar
• De RV, Oliva A, Messore B, Grosso B, Mollar C, Pozzi E. Circulating adhesion molecules in cystic fibrosis. Am J Respir Crit Care Med 1998; 157: 1234–9.
   PubMedGoogle Scholar
• Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157: 776–84.
   Google Scholar
• Nordoy I, Aukrust P, Muller F, Froland SS. Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections. Clin Immunol Immunopathol 1996; 81: 16–21.
   PubMedGoogle Scholar
• Yang SS, Tsai G, Wu CH, Chen DS. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis. Hepatogastroenterology 1996; 43: 575–81.
   PubMedGoogle Scholar
• Nakae H, Endo S, Inada K, Takakuwa T, Kasai T. Changes in adhesion molecule levels in sepsis. Res Commun Mol Pathol Pharmacol 1996; 91: 329–38.
   PubMedGoogle Scholar
• Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intens Care Med 1996; 22: 122–8.
   Google Scholar
• Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, et al. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 1995; 46: 212–9.
   PubMedGoogle Scholar
• Yamamoto T, Osaki T, Yoneda K, Ueta E. Immunological investigation of adult patients with primary herpes simplex virus-1 infection. J Oral Pathol Med 1993; 22: 263–7.
   PubMedGoogle Scholar
• Venge P, Strömberg A, Braconier JH, Roxin L-E, Olsson I. Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol 1978; 38: 475–83.
   PubMed Web of Science ®Google Scholar
• Karawajczyk M, Pauksen K, Peterson CGB, Eklund E, Venge P. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin Exp Allergy 1995; 25: 713–9.
   Google Scholar
• Spitznagel JK, Dalldorf FG, Leffell MS, Folds JD, Welsh IRH, Cooney MH, Martin LE. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest 1974; 30: 774–85.
   Google Scholar
• Karle H, Hansen NE, Killmann S-A. Intracellular lysozyme in mature neutrophils and blast cells in acute leukemia. Blood 1974; 44: 247–55.
   Google Scholar
• Osserman EF. Lysozyme. N Engl J Med 1975; 292: 424–5.
   PubMedGoogle Scholar
• Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Naka-bayashi K, Kitamoto K, et al. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993; 40: 256–64.
   Google Scholar
• Richter HE, Holley RL, Andrews WW, Owen J, Miller KB. The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease. Am J Obstet Gynecol 1999; 181: 940–4.
   Google Scholar
• Donald RA, Bailey RR, Hart D, Livesey JH, Evans MJ, Mattioli L, et al. The plasma interleukin-6 and stress hormone responses to acute pyelonephritis. J Endocrinol Invest 1994; 17: 263–8.
   PubMedGoogle Scholar
• Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886–90.
   PubMed Web of Science ®Google Scholar